Today: 20 May 2026
iFAST (SGX:AIY) share price slides as Asia turns risk-off; Feb 12 results in focus
2 February 2026
1 min read

iFAST (SGX:AIY) share price slides as Asia turns risk-off; Feb 12 results in focus

Singapore, Feb 2, 2026, 15:48 SGT — Regular session

iFAST shares dropped 2.4% to S$10.29 by Monday afternoon. The Singapore wealth platform is set to announce its unaudited full-year results after the market closes on Feb. 12.

The decline followed a selloff in precious metals that spilled into wider markets, making investors wary ahead of a busy week packed with corporate earnings, central bank decisions, and major economic reports.

iFAST operates a digital banking and wealth management platform, offering investment products and services to both institutional and retail clients throughout Asia, according to a Reuters company profile. This business model can make the stock vulnerable during market fluctuations and periods of reduced investor trading.

The stock fluctuated between S$10.19 and S$10.54 in the session, with about 1.25 million shares changing hands, according to Investing.com data. It ended Friday at S$10.54.

“It’s risk off and de-leveraging — a flushing out of leverage in the system,” said Christopher Forbes, head of Asia and the Middle East at CMC Markets. Margin calls happen when brokers demand extra cash after positions turn against investors. Reuters

Focus shifts to whether iFAST can maintain steady net inflows—the difference between funds entering and leaving—and safeguard its margins when it reports. Investors will also watch for updates on its digital bank and broader expansion efforts.

In January, iFAST announced a conditional agreement to acquire a 30% stake in Financial Alliance Corporation Limited for S$19.6 million, pending regulatory clearance in both Singapore and Malaysia.

The immediate trigger is price action. Continued forced selling in the markets could drag down smaller financial stocks, even in the absence of new company developments.

Despite Monday’s dip, iFAST shares have climbed roughly 8% year-to-date, according to MarketScreener data.

Traders are watching to see if the selloff slows before the market closes. Any signs of steadiness in commodities and U.S. futures could provide some relief.

Stock Market Today

  • Stock Market Continues Modest Pullback as Leading Growth Stocks Hold
    May 19, 2026, 7:45 PM EDT. The stock market extended its losing streak to three sessions on Tuesday, marking a modest and orderly pullback. Despite the slump, leading growth stocks demonstrated resilience, showing signs of underlying strength amid broader market pressure. Investors are watching carefully as the overall market digests recent gains, while specific oil and gas companies attract attention for potential opportunities. This cautious environment suggests investors are balancing profit-taking with selective buying in sectors showing robust performance.

Latest articles

GCL Global Stock’s Wild After-Hours Jump: The $10 Million ADATA Deal Behind the Move

GCL Global Stock’s Wild After-Hours Jump: The $10 Million ADATA Deal Behind the Move

20 May 2026
GCL Global Holdings shares jumped to $1.00 after hours Tuesday, up 132%, following news that ADATA Technology invested another $10 million in its 4Divinity unit. The stock had closed regular trading at $0.43, below Nasdaq’s $1 minimum. Recent filings still warn of listing and execution risks. GCL reported first-half revenue up 94% to $98.7 million but posted a net loss of $5.6 million.
James Hardie Drops After Warning on Housing, Even With Q4 Beat

James Hardie Drops After Warning on Housing, Even With Q4 Beat

20 May 2026
James Hardie’s U.S.-listed shares dropped 6.1% Tuesday and slid another 2.6% after hours after reporting a 35% fall in quarterly net income to $28.5 million, despite a 45% jump in net sales to $1.40 billion. The company cited weak housing demand and warned the market remains uncertain. ASX shares had not traded post-earnings; they last closed at A$26.78, up 2.9%.
SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

20 May 2026
SELLAS Life Sciences shares rose 4.1% to $7.59 Tuesday after CEO Angelos Stergiou said its Phase 3 AML trial is two events from final analysis. The company reported $107.1 million in cash and a first-quarter net loss of $8.4 million. The REGAL trial’s main measure is overall survival. SELLAS remains blinded to results until the 80th event triggers data review.
ST Engineering share price slips after NeuSAR-2 satellite plan and Singapore’s new space agency
Previous Story

ST Engineering share price slips after NeuSAR-2 satellite plan and Singapore’s new space agency

Samsung Electronics stock price dives 6% in Seoul selloff — what to watch before Tuesday’s open
Next Story

Samsung Electronics stock price dives 6% in Seoul selloff — what to watch before Tuesday’s open

Go toTop